ROHTO PHARMACEUTICAL CO.,LTD.
Loading...
Key Metrics
Market Cap
N/A
P/E Ratio
N/A
P/B Ratio
N/A
Revenue
308.6B
Net Income
31.0B
Gross Margin
N/A
Op. Margin
12.6%
Net Margin
10.0%
ROE
11.4%
ROA
7.3%
D/E
0.55
Dividend Yield
N/A
EPS
136.11
Current Ratio
2.30
Price History
Company Info
| Industry | PHARMACEUTICAL |
| Market Segment | Prime |
| Accounting | Japan GAAP |
| Currency | JPY |
| Fiscal Year | 2025 |
Peers
GNI Group Ltd.
2160
--
P/E: --
Kyowa Kirin Co.,Ltd.
4151
--
P/E: --
--
P/E: --
Astellas Pharma Inc.
4503
--
P/E: --
--
P/E: --
Shionogi & Co.,Ltd.
4507
--
P/E: --
--
P/E: --
--
P/E: --
Financial Statements
Loading financials...
Open Advanced Charts
Full charting with technical indicators, candlestick, and more.
| Ticker | 4527 |
| Exchange | TSE |
| Sector | Pharmaceutical |
| Industry | PHARMACEUTICAL |